SITE013-0256

SITE013 (USA) › SITE013-0256

SITE013-0256

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE013 (USA) · Dr. Clarke
consented 2026-07-01

enrolled

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-03-08 (study day 61); relationship: RELATED

mild assessed

Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-02-13 (study day 38); relationship: not assessed

mild assessed

Grade 1 Anaemia — outcome: UNKNOWN; onset 2023-01-08 (study day 2); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.